Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
BJU International|November 10, 2019
Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancerStephen Langley, Jennifer Uribe, Santiago Uribe-Lewis, et al.Plos Genetics|December 4, 2009
Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locusRaffaella Nativio, Kerstin S Wendt, Yoko Ito, et al.BJU International|August 30, 2021
Robot-assisted salvage seminal vesicle excision for isolated recurrence after low-dose-rate prostate brachytherapyStephen Langley, Christopher Eden, Matthew Perry, et al.BJU International|August 27, 2021
Long-term survival after low-dose-rate brachytherapy for prostate cancer: the Royal Surrey experienceSantiago Uribe-Lewis, Jennifer Uribe, Vincent Bourke, et al.Brachytherapy|March 27, 2024
Net survival of men with localized prostate cancer after LDR brachytherapySantiago Uribe-Lewis, Jennifer Uribe, Claire Deering, et al.Cell Reports|December 22, 2015
Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the EpigenomeAna Tufegdzic Vidakovic, Oscar M Rueda, Stephin J Vervoort, et al.Brachytherapy|October 7, 2022
Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?Stephen Langley, Jennifer Uribe, Santiago Uribe-Lewis, et al.Nature Cell Biology|June 26, 2012
Diverse epigenetic strategies interact to control epidermal differentiationKlaas W Mulder, Xin Wang, Carles Escriu, et al.Nature Communications|February 3, 2016
Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functionsLovorka Stojic, Malwina Niemczyk, Arturo Orjalo, et al.BMJ Open|April 27, 2026
The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancerWilliam Hayhurst, Santiago Uribe-Lewis, Jennifer Uribe, et al.Pageof 3